Evidence map›Paper›PMID 34191585›Full record

ArticleJournal of clinical microbiology2021

Implementation of SARS-CoV2 Screening in K-12 Schools Using In-School Pooled Molecular Testing and Deconvolution by Rapid Antigen Test.

Nira R Pollock, David Berlin, Sandra C Smole, Lawrence C Madoff, Catherine Brown, Kelsey Henderson, Elizabeth Larsen, Jeremiah Hay, Stacey Gabriel, Atul A Gawande and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Nira R PollockDepartment of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
David BerlinCIC Health, Cambridge, Massachusetts, USA.
Sandra C SmoleMassachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA.
Lawrence C MadoffMassachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA.
Catherine BrownMassachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA.
Kelsey HendersonCIC Health, Cambridge, Massachusetts, USA.
Elizabeth LarsenExecutive Office of Health and Human Services, Massachusetts Department of Health and Human Services, Boston, Massachusetts, USA.
Jeremiah HayExecutive Office of Health and Human Services, Massachusetts Department of Health and Human Services, Boston, Massachusetts, USA.
Stacey GabrielBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Atul A GawandeCIC Health, Cambridge, Massachusetts, USA.
Niall J LennonBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Massachusetts Department of Public Health · USBroad Institute · USMassachusetts Executive Office of Health and Human Services · USBoston Children's Hospital · USBrigham and Women's Hospital · US

Funding

Commonwealth of MassachusettsHHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) RADx ATPNCEZID CDC HHS NU50CK000518U.S. Department of Health and Human Services (HHS) NU50CK000518-02-06
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) testing is one component of a multilayered mitigation strategy to enable safe in-person school attendance for the K-12 school population. However, costs, logistics, and uncertainty about effectiveness are potential barriers to implementation. We assessed early data from the Massachusetts K-12 public school pooled SARS-CoV2 testing program, which incorporates two novel design elements: in-school "pod pooling" for assembling pools of dry anterior nasal swabs from 5 to 10 individuals and positive pool deconvolution using the BinaxNOW antigen rapid diagnostic test (Ag RDT), to assess the operational and analytical feasibility of this approach. Over 3 months, 187,597 individual swabs were tested across 39,297 pools from 738 schools. The pool positivity rate was 0.8%; 98.2% of pools tested negative and 0.2% inconclusive, and 0.8% of pools submitted could not be tested. Of 310 positive pools, 70.6% had an N1 or N2 probe cycle threshold (

Indexed as

COVID-19RNA, ViralHumansMolecular Diagnostic TechniquesSARS-CoV-2SchoolsSpecimen HandlingRNA, ViralantigenpooledreflexSARS-CoV2schoolsscreeningtesting

Identifiers

PMID34191585
PMCPMC8373013
OpenAlexW3174947612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.